| Patent | Date |
|---|
Human EPO Mimetic Hinge Core Mimetibodies, Compositions, Methods and Uses
App 20100249032 - Heavner; George A. ; et al. | 2010-09-30 |
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
Grant 7,718,176 - Heavner , et al. May 18, 2 | 2010-05-18 |
Human Epo Mimetic Hinge Core Mimetibodies, Compositions, Methods And Uses
App 20090220506 - HEAVNER; GEORGE A. ; et al. | 2009-09-03 |
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
Grant 7,393,662 - Heavner , et al. July 1, 2 | 2008-07-01 |
Anti-IL-13 antibodies, compositions, methods and uses
App 20080044420 - Heavner; George A. ; et al. | 2008-02-21 |
Treating renal cell carcinoma with an anti-TNF human antibody or fragment
App 20070160606 - Heavner; George A. ; et al. | 2007-07-12 |
Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
Grant 7,241,733 - Heavner , et al. July 10, 2 | 2007-07-10 |
Peptide with osteogenic activity
Grant 7,163,920 - Dhanaraj , et al. January 16, 2 | 2007-01-16 |
Methods and compositions for treating renal cell carcinoma related pathologies
App 20060246070 - Heavner; George A. ; et al. | 2006-11-02 |
Hinge core mimetibodies, compositions, methods and uses
App 20060127404 - Huang; ChiChi ; et al. | 2006-06-15 |
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
App 20060051844 - Heavner; George A. ; et al. | 2006-03-09 |
Methods and compositions for treating IL-3 related pathologies
App 20050266005 - Heavner, George A. ; et al. | 2005-12-01 |
Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
App 20050191301 - Heavner, George A. ; et al. | 2005-09-01 |
Novel peptide with osteogenic activity
App 20050187162 - Dhanaraj, Sridevi ; et al. | 2005-08-25 |
Interleukin-21 analogs
App 20050124044 - Cunningham, Mark R. ; et al. | 2005-06-09 |
IL-13 mutein proteins, antibodies, compositions, methods and uses
App 20040248260 - Heavner, George A. ; et al. | 2004-12-09 |
Asthma-related anti-IL-13 immunoglobulin derived proteins, compositions, methods and uses
App 20040234499 - Shealy, David ; et al. | 2004-11-25 |
Epitope mapping using nuclear magnetic resonance
App 20040185506 - Heavner, George A. | 2004-09-23 |
MCP-1 mutant proteins, antibodies, compositions, methods and uses
App 20040185450 - Heavner, George A. ; et al. | 2004-09-23 |
IL-13 mutein proteins, antibodies, compositions, methods and uses
App 20040023337 - Heavner, George A. ; et al. | 2004-02-05 |
Mut-IL-18 or Mut-IL-18R proteins, antibodies, compositions, methods and uses
App 20040023336 - Heavner, George A. ; et al. | 2004-02-05 |
IL-4 mutein proteins, antibodies, compositions, methods and uses
App 20040023338 - Heavner, George A. ; et al. | 2004-02-05 |
Pseudo-antibody constructs
App 20030211078 - Heavner, George A. | 2003-11-13 |
Peptide inhibitors of inflammation mediated by selectins
App 20030144211 - Heavner, George A. ; et al. | 2003-07-31 |
Peptide inhibitors of inflammation mediated by selectins
Grant 6,528,487 - Heavner , et al. March 4, 2 | 2003-03-04 |
Peptide inhibitors of inflammation mediated by selectins
Grant 6,111,065 - Heavner , et al. August 29, 2 | 2000-08-29 |
Peptide inhibitors of cellular adhesion
Grant 5,753,617 - Heavner , et al. May 19, 1 | 1998-05-19 |
Peptide inhibitors of selectin binding
Grant 5,710,123 - Heavner , et al. January 20, 1 | 1998-01-20 |
Tumor necrosis factor inhibitors
Grant 5,641,751 - Heavner June 24, 1 | 1997-06-24 |
Peptide inhibitors of selectin binding
Grant 5,618,785 - Heavner , et al. April 8, 1 | 1997-04-08 |
Tumor necrosis factor inhibitors
Grant 5,486,595 - Heavner January 23, 1 | 1996-01-23 |
(Substituted)ureidoacetohydroxamic acids
Grant 4,028,401 - Fessler , et al. June 7, 1 | 1977-06-07 |
| 